TrialX Updates: Supporting Health Research Data Collection for Fram2 Space Mission, AI in Patient Recruitment and more…
We are thrilled to announce that, in partnership with the Translational Research Institute for Space Health, TrialX played a crucial role in facilitating health research data collection for the groundbreaking Fram2 mission – the first human spaceflight to orbit Earth’s polar regions. For this mission, TrialX supported the collection of physiological data—including heart rate, heart rate variability, respiration rate, stress levels, and SpO2 etc.—using wearables such as Garmin smartwatches and BioButton sensors. Building on our decentralized research expertise, we’re proud to help advance health data collection beyond Earth. Learn more.
What’s New at TrialX! 🚀
📢 PRODUCT UPDATES
Language should not be a barrier to finding the right clinical trial. At TrialX, we’re making research more inclusive by empowering study teams to connect with participants in up to 10 different languages—bringing clinical trials closer to the communities that need them most. More languages supported means more access. More access means better outreach. Learn how we’re breaking down barriers to boost trial awareness and participation.
Recent enhancements in our patient recruitment management system makes scheduling smoother and more flexible for both patients and site teams. Clinical trial sites can now set and share their availability with patients, who can pick a convenient time slot during the referral process. Site staff can confirm or adjust the slot via email or the referral page, and both parties receive a confirmation email once it’s finalized.
RECENT CURETALKS 
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Lola App Pilot Study: Indiana University’s CARE project is inviting African American/Black adults aged 45 and older to join a 4-week pilot study testing the Lola app, which offers education on Alzheimer’s and dementia, community resources, and health news. Participants will use the app from home and provide feedback to help improve dementia-related outreach and technology.
ASPIRION – Celiac Disease: Researchers are studying an investigational medication for adults aged 18 to 75 with non-responsive celiac disease (NRCD) who continue to have moderate or greater gastrointestinal symptoms despite being on a gluten-free diet for at least 12 months. The study will assess how the medication affects small intestine structure and symptoms compared to a placebo, over a period of up to 48 weeks.
Acne Research Study: Penn Medicine is recruiting women aged 16 to 40 with moderate to severe acne for a study comparing the effectiveness of Spironolactone & Doxycycline Hyclate. The 16-week study includes skin assessments and optional microbiome sampling. Participants must have at least 10 facial pimples, be assigned female at birth, and not be pregnant or trying to conceive.
Fox Insight Online Study: The Michael J. Fox Foundation invites people with and without Parkinson’s to join Fox Insight, an online clinical study collecting real-world data to fuel Parkinson’s research. Participants complete online surveys every 90 days, sharing insights on symptoms, daily life, and more.
🌎 AROUND THE WEB
🧑🚀️ Upcoming Ax-4 mission: TRISH to lead innovative human health research
💩 Gut feeling: Fecal transplants show promise in autism clinical trials.
🔍 Martian mystery: Curiosity rover uncovers a major clue to Mars’ habitability.
🧠 Smarter sparks: Adaptive brain stimulation offers new hope for Parkinson’s.
👽 AI x Alien worlds: Artificial intelligence is helping scientists find Earth 2.0.
🤝 TEAM UPDATES
AI IN PATIENT RECRUITMENT – INSIGHTS & EXPERIENCES
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
All the best,
Team TrialX
